Robert V. Talanian

10.2k total citations · 4 hit papers
55 papers, 8.2k citations indexed

About

Robert V. Talanian is a scholar working on Molecular Biology, Physiology and Immunology. According to data from OpenAlex, Robert V. Talanian has authored 55 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 12 papers in Physiology and 12 papers in Immunology. Recurrent topics in Robert V. Talanian's work include Cell death mechanisms and regulation (19 papers), Protein Kinase Regulation and GTPase Signaling (8 papers) and Neuroinflammation and Neurodegeneration Mechanisms (6 papers). Robert V. Talanian is often cited by papers focused on Cell death mechanisms and regulation (19 papers), Protein Kinase Regulation and GTPase Signaling (8 papers) and Neuroinflammation and Neurodegeneration Mechanisms (6 papers). Robert V. Talanian collaborates with scholars based in United States, Germany and United Kingdom. Robert V. Talanian's co-authors include Young‐Myeong Kim, Timothy R. Billiar, Shigekazu Nagata, Masato Enari, Tariq Ghayur, Winnie W. Wong, Jianrong Li, Timothy R. Billiar, David Banach and Kenneth D. Brady and has published in prestigious journals such as Nature, Science and Journal of Biological Chemistry.

In The Last Decade

Robert V. Talanian

55 papers receiving 8.1k citations

Hit Papers

Caspase-1 processes IFN-γ-inducing factor and regulates L... 1996 2026 2006 2016 1997 1996 1997 1997 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN- γ production
    1997 1.0k citations Tariq Ghayur, Robert V. Talanian et al. profile →
  2. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis
    1996 902 citations Robert V. Talanian et al. profile →
  3. Substrate Specificities of Caspase Family Proteases
    1997 768 citations Robert V. Talanian, David Banach et al. Journal of Biological Chemistry profile →
  4. Nitric Oxide Inhibits Apoptosis by Preventing Increases in Caspase-3-like Activity via Two Distinct Mechanisms
    1997 763 citations Young‐Myeong Kim, Robert V. Talanian et al. Journal of Biological Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert V. Talanian United States 33 5.8k 2.1k 1.2k 956 880 55 8.2k
John P. Vaillancourt Canada 19 6.4k 1.1× 1.6k 0.8× 755 0.6× 941 1.0× 1.2k 1.4× 24 8.3k
Junji Yodoi Japan 62 7.2k 1.2× 3.6k 1.7× 1.3k 1.1× 813 0.9× 705 0.8× 209 12.1k
Tamera Barrett United States 28 7.0k 1.2× 1.6k 0.8× 1.2k 1.1× 1.3k 1.4× 1.8k 2.0× 28 9.9k
Chris J. Vlahos United States 36 5.8k 1.0× 1.1k 0.5× 939 0.8× 1.0k 1.1× 928 1.1× 68 8.5k
Toshiro Okazaki Japan 46 4.9k 0.9× 1.5k 0.7× 1.3k 1.1× 1.1k 1.2× 1.0k 1.1× 137 7.1k
Scott G. Morham United States 37 3.4k 0.6× 1.2k 0.6× 824 0.7× 1.5k 1.6× 776 0.9× 50 9.1k
Christina C. Leslie United States 49 4.9k 0.8× 1.3k 0.6× 1.3k 1.1× 1.2k 1.3× 479 0.5× 100 7.8k
Nika N. Danial United States 35 7.2k 1.2× 1.5k 0.7× 1.1k 0.9× 801 0.8× 1.5k 1.7× 56 10.4k
Jesús Balsinde Spain 59 6.1k 1.1× 1.3k 0.6× 1.3k 1.1× 1.2k 1.2× 383 0.4× 147 9.1k
Brian Leber Canada 49 6.3k 1.1× 1.2k 0.6× 831 0.7× 576 0.6× 1.3k 1.4× 196 9.5k

Countries citing papers authored by Robert V. Talanian

Since Specialization
Citations

This map shows the geographic impact of Robert V. Talanian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert V. Talanian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert V. Talanian more than expected).

Fields of papers citing papers by Robert V. Talanian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert V. Talanian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert V. Talanian. The network helps show where Robert V. Talanian may publish in the future.

Co-authorship network of co-authors of Robert V. Talanian

This figure shows the co-authorship network connecting the top 25 collaborators of Robert V. Talanian. A scholar is included among the top collaborators of Robert V. Talanian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert V. Talanian. Robert V. Talanian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bryant, Annie G., Zhaozhi Li, Alberto Serrano‐Pozo, et al.. (2023). Endothelial Cells Are Heterogeneous in Different Brain Regions and Are Dramatically Altered in Alzheimer's Disease. Journal of Neuroscience. 43(24). 4541–4557. 31 indexed citations
2.
Li, Zhaozhi, Astrid Wachter, Ayush Noori, et al.. (2023). The APOEε4 allele exacerbates the transcriptomic responses to Aβ plaques and neurofibrillary tangles in Alzheimer’s disease. Alzheimer s & Dementia. 19(S1). 1 indexed citations
3.
Schapansky, Jason, Yelena Y. Grinberg, Stephen G. Walker, et al.. (2020). MEK1/2 activity modulates TREM2 cell surface recruitment. Journal of Biological Chemistry. 296. 100218–100218. 10 indexed citations
4.
Biber, Knut, Anindya Bhattacharya, Brian Campbell, et al.. (2019). Microglial Drug Targets in AD: Opportunities and Challenges in Drug Discovery and Development. Frontiers in Pharmacology. 10. 840–840. 28 indexed citations
5.
Galatsis, Paul, Bradley W. Caprathe, John L. Gilmore, et al.. (2010). Succinic acid amides as P2–P3 replacements for inhibitors of interleukin-1β converting enzyme (ICE or caspase 1). Bioorganic & Medicinal Chemistry Letters. 20(17). 5184–5190. 16 indexed citations
6.
Galatsis, Paul, Bradley W. Caprathe, Dennis M. Downing, et al.. (2010). Inhibition of interleukin-1β converting enzyme (ICE or caspase 1) by aspartyl acyloxyalkyl ketones and aspartyl amidooxyalkyl ketones. Bioorganic & Medicinal Chemistry Letters. 20(17). 5089–5094. 6 indexed citations
7.
Jia, Yong, et al.. (2008). Current In Vitro Kinase Assay Technologies: The Quest for a Universal Format. Current Drug Discovery Technologies. 5(1). 59–69. 67 indexed citations
8.
Jia, Yong, et al.. (2006). Homogeneous time-resolved fluorescence and its applications for kinase assays in drug discovery. Analytical Biochemistry. 356(2). 273–281. 85 indexed citations
9.
Arnold, Lee D., R.A. Dixon, Robert V. Talanian, et al.. (2002). Molecular interactions in crystal structures of potent inhibitors bound to the kinase domain of Tie-2. 43. 848. 2 indexed citations
10.
Shahripour, Aurash, Mark S. Plummer, Elizabeth A. Lunney, et al.. (2002). Structure-Based design of nonpeptide inhibitors of interleukin-1β converting enzyme (ICE, Caspase-1). Bioorganic & Medicinal Chemistry. 10(1). 31–40. 21 indexed citations
11.
Krippner‐Heidenreich, Anja, Robert V. Talanian, Renate Sekul, et al.. (2001). Targeting of the transcription factor Max during apoptosis: phosphorylation-regulated cleavage by caspase-5 at an unusual glutamic acid residue in position P1. Biochemical Journal. 358(3). 705–705. 93 indexed citations
12.
Smith, Lucinda, Lei Chen, Mary E. Reyland, et al.. (2000). Activation of Atypical Protein Kinase C ζ by Caspase Processing and Degradation by the Ubiquitin-Proteasome System. Journal of Biological Chemistry. 275(51). 40620–40627. 70 indexed citations
13.
Kim, Young‐Myeong, Tae‐Hyoung Kim, Dai‐Wu Seol, Robert V. Talanian, & Timothy R. Billiar. (1998). Nitric Oxide Suppression of Apoptosis Occurs in Association with an Inhibition of Bcl-2 Cleavage and Cytochrome cRelease. Journal of Biological Chemistry. 273(47). 31437–31441. 213 indexed citations
14.
Wang, Kevin, Rand Posmantur, Ravi Nadimpalli, et al.. (1998). Caspase-Mediated Fragmentation of Calpain Inhibitor Protein Calpastatin during Apoptosis. Archives of Biochemistry and Biophysics. 356(2). 187–196. 217 indexed citations
15.
Talanian, Robert V., Jane M. Turbov, Prem Seth, et al.. (1997). Granule-mediated Killing: Pathways for Granzyme B–initiated Apoptosis. The Journal of Experimental Medicine. 186(8). 1323–1331. 157 indexed citations
16.
Maravei, Daniel V., Alexander M. Trbovich, Gloria I. Perez, et al.. (1997). Cleavage of cytoskeletal proteins by caspases during ovarian cell death: evidence that cell-free systems do not always mimic apoptotic events in intact cells. Cell Death and Differentiation. 4(8). 707–712. 35 indexed citations
17.
Kim, Young‐Myeong, Robert V. Talanian, & Timothy R. Billiar. (1997). Nitric Oxide Inhibits Apoptosis by Preventing Increases in Caspase-3-like Activity via Two Distinct Mechanisms. Journal of Biological Chemistry. 272(49). 31138–31148. 763 indexed citations breakdown →
18.
Li, Jianrong, Timothy R. Billiar, Robert V. Talanian, & Young Mo Kim. (1997). Nitric Oxide Reversibly Inhibits Seven Members of the Caspase Family via S-Nitrosylation. Biochemical and Biophysical Research Communications. 240(2). 419–424. 433 indexed citations
19.
Talanian, Robert V. & George E. Wright. (1990). The roles of DNA polymerases alpha and delta in DNA replication. Pharmacology & Therapeutics. 47(1). 105–115. 1 indexed citations
20.
Talanian, Robert V., et al.. (1989). Carbonyldiphosphonate, a selective inhibitor of mammalian DNA polymerase .delta.. Biochemistry. 28(21). 8270–8274. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John P. Vaillancourt Breakdown of academic impact, for papers by Junji Yodoi Breakdown of academic impact, for papers by Tamera Barrett Breakdown of academic impact, for papers by Chris J. Vlahos Breakdown of academic impact, for papers by Toshiro Okazaki Breakdown of academic impact, for papers by Scott G. Morham Breakdown of academic impact, for papers by Christina C. Leslie Breakdown of academic impact, for papers by Nika N. Danial Breakdown of academic impact, for papers by Jesús Balsinde Breakdown of academic impact, for papers by Brian Leber
Rankless by CCL
2026